GENE ONLINE|News &
Opinion
Blog

FDA Approval
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Bristol Myers Scores FDA Approval for Opdivo-Yervoy Combination as First-Line HCC Therapy
2025-04-14
Massachusetts Biotech Faces Prolonged Slump Amid Economic and Regulatory Uncertainty
2025-03-31
FDA Greenlights Soleno Therapeutics’ VYKAT XR for PWS Hyperphagia
2025-03-28
FDA Approves New Oral Antibiotic for Urinary Tract Infections
2025-03-27
Character Biosciences Secures $93M for Clinical Trials Targeting Dry AMD
2025-03-26
Bristol Myers Squibb Acquires Cancer Cell Therapy Partner 2seventy Bio in $286M Deal
2025-03-12
Double Win With FDA’s Green Light Towards Two New Denosumab Biosimilars
2025-03-05
Zevra Therapeutics Sells $150 Million FDA Priority Review Voucher
2025-02-28
FDA Approves Merilog: What It Means for the Diabetes Biosimilar Market
2025-02-19
GSK’s Penmenvy Secures FDA Approval to Combat Five Major Meningococcal Serogroups Among Youth
2025-02-17
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
FDA Grants First-Ever Approval for MSC Therapy to Australian Company Mesoblast After Attempting for 4 Years
2024-12-20
FDA Approves Kebilidi: First Brain-Delivered Gene Therapy for Rare AADC Disease
2024-11-15
FDA Greenlights First At-Home, Over-the-Counter Syphilis Diagnostic Test Amidst STD Increase
2024-08-21
1 2 3 11
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top